Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mitotic protein kinase CDK1 phosphorylation of mRNA translation regulator 4E-BP1 Ser83 may contribute to cell transformation
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 113, Issue 30, Pages 8466-8471
Publisher
Proceedings of the National Academy of Sciences
Online
2016-07-12
DOI
10.1073/pnas.1607768113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Regulation of Poly(A) Tail and Translation during the Somatic Cell Cycle
- (2016) Jong-Eun Park et al. MOLECULAR CELL
- Eukaryotic initiation factor 4E-binding protein 1 (4E-BP1): a master regulator of mRNA translation involved in tumorigenesis
- (2016) J Musa et al. ONCOGENE
- Molecular Architecture of 4E-BP Translational Inhibitors Bound to eIF4E
- (2015) Daniel Peter et al. MOLECULAR CELL
- CDK1 substitutes for mTOR kinase to activate mitotic cap-dependent protein translation
- (2015) Masahiro Shuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular mechanism of the dual activity of 4EGI-1: Dissociating eIF4G from eIF4E but stabilizing the binding of unphosphorylated 4E-BP1
- (2015) Naotaka Sekiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels
- (2014) Philipp Mertins et al. MOLECULAR & CELLULAR PROTEOMICS
- Casein Kinase 1 Promotes Cell Proliferation by Regulating mRNA Translation
- (2013) S. Shin et al. CANCER RESEARCH
- Glycogen synthase kinase-3β positively regulates protein synthesis and cell proliferation through the regulation of translation initiation factor 4E-binding protein 1
- (2013) S Shin et al. ONCOGENE
- 4E-BP1 participates in maintaining spindle integrity and genomic stability via interacting with PLK1
- (2012) Zeng-Fu Shang et al. CELL CYCLE
- Morphine Produces Immunosuppressive Effects in Nonhuman Primates at the Proteomic and Cellular Levels
- (2012) Joseph N. Brown et al. MOLECULAR & CELLULAR PROTEOMICS
- Anti-oncogenic potential of the eIF4E-binding proteins
- (2012) Y Martineau et al. ONCOGENE
- A conserved motif within the flexible C-terminus of the translational regulator 4E-BP is required for tight binding to the mRNA cap-binding protein eIF4E
- (2011) Keum Soon Paku et al. BIOCHEMICAL JOURNAL
- Human Merkel cell polyomavirus small T antigen is an oncoprotein targeting the 4E-BP1 translation regulator
- (2011) Masahiro Shuda et al. JOURNAL OF CLINICAL INVESTIGATION
- Mechanisms of mTOR inhibitor resistance in cancer therapy
- (2011) Jennifer S. Carew et al. Targeted Oncology
- 4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
- (2010) Qing-Bai She et al. CANCER CELL
- The mechanism of eukaryotic translation initiation and principles of its regulation
- (2010) Richard J. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The translational repressor 4E-BP called to order by eIF4E: new structural insights by SAXS
- (2010) Pauline Gosselin et al. NUCLEIC ACIDS RESEARCH
- mTORC1 signaling: what we still don't know
- (2010) X. Wang et al. Journal of Molecular Cell Biology
- An overview of Cdk1-controlled targets and processes
- (2010) Jorrit M Enserink et al. Cell Division
- Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2
- (2009) Morris E Feldman et al. PLOS BIOLOGY
- Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila
- (2008) Yuzuru Imai et al. EMBO JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started